State Street’s TuHURA Biosciences HURA Stock Holding History

State Street’s Portfolio HURA Stock Details HURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$441K	Sell	188,404 -324,509	-63%	-$756K	﹤0.01%	3620
2026 Q1	$918K	Buy	512,913 +223,780	+77%	+$274K	﹤0.01%	3505
2025 Q4	$219K	Buy	289,133 +13,594	+5%	+$26K	﹤0.01%	3880
2025 Q3	$683K	Buy	275,539 +47,159	+21%	+$124K	﹤0.01%	3597
2025 Q2	$509K	Buy	228,380 +197,574	+641%	+$668K	﹤0.01%	3615
2025 Q1	$99.5K	Buy	30,806 +7,800	+34%	+$28.8K	﹤0.01%	3979
2024 Q4	$94.1K	Buy	23,006 +22,700	+7,418%	+$121K	﹤0.01%	4000
2024 Q3	$2.09K	Hold	306	–	–	﹤0.01%	4290
2024 Q2	$2.9K	Hold	306	–	–	﹤0.01%	4357
2024 Q1	$1.11K	Hold	306	–	–	﹤0.01%	4363
2023 Q4	$1.82K	Hold	306	–	–	﹤0.01%	4431
2023 Q3	$43.4K	Hold	306	–	–	﹤0.01%	4318
2023 Q2	$43.2K	Hold	306	–	–	﹤0.01%	4456
2023 Q1	$39.5K	Hold	306	–	–	﹤0.01%	4562
2022 Q4	$73.9K	Buy	306 +240	+364%	+$53.3K	﹤0.01%	4456
2022 Q3	$13K	Hold	66	–	–	﹤0.01%	4873
2022 Q2	$32K	Hold	66	–	–	﹤0.01%	4806
2022 Q1	$46K	Hold	66	–	–	﹤0.01%	4808
2021 Q4	$59K	Hold	66	–	–	﹤0.01%	4672
2021 Q3	$100K	Buy	66 +4	+6%	+$10.5K	﹤0.01%	4548
2021 Q2	$245K	Buy	62 +54	+675%	+$155K	﹤0.01%	4139
2021 Q1	$24K	Hold	8	–	–	﹤0.01%	3960
2020 Q4	$18K	Hold	8	–	–	﹤0.01%	3870
2020 Q3	$19K	Buy	+8	New	+$16.1K	﹤0.01%	3797

Other funds holding HURA

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

AWM

Apollon Wealth Management Mount Pleasant, South Carolina $8.23B AUM 30.88% 1-Year Est. Return

State Street's HURA Position: Q2 2026 in Review

State Street reduced its TuHURA Biosciences (HURA) stake by 63% in Q2 2026, selling an estimated $756K and leaving 188,404 shares worth $441K. The position accounts for ﹤0.01% of the portfolio, ranked #3620.

State Street first reported a position in HURA in Q3 2020 and has held it in 24 quarters since. The position peaked at $918K in Q1 2026. 90 funds tracked by Wall St. Rank hold HURA as of Q2 2026.

State Street held 188,404 shares of TuHURA Biosciences worth $441K as of Q2 2026.
State Street sold 324,509 TuHURA Biosciences shares in Q2 2026, an estimated $756K.
TuHURA Biosciences made up ﹤0.01% of State Street's portfolio in Q2 2026, its #3620 holding.
State Street first reported a position in TuHURA Biosciences in Q3 2020 and has held it in 24 quarters since.
State Street's TuHURA Biosciences position peaked at $918K in Q1 2026.
90 funds tracked by Wall St. Rank held TuHURA Biosciences as of Q2 2026.

Based on State Street's 13F filing for Q2 2026, filed 7 Aug 2026.